Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy

Gastric cancer is characterized by high morbidity and mortality worldwide. Early-stage gastric cancer is mainly treated with surgery, while for advanced gastric cancer, the current treatment options remain insufficient. In the 2022 NCCN Guidelines for Gastric Cancer, immunotherapy is listed as a fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Hongzhen, Li, Man, Deng, Ruiyi, Wang, Mopei, Shi, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426247/
https://www.ncbi.nlm.nih.gov/pubmed/36042469
http://dx.doi.org/10.1186/s40364-022-00413-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426247/
https://www.ncbi.nlm.nih.gov/pubmed/36042469
http://dx.doi.org/10.1186/s40364-022-00413-0

Ejemplares similares